Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07503925 · ClinicalTrials.gov registry record · Phase 4
THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health
A Phase 4 study, sponsored by Ohio State University Comprehensive Cancer Center.
- Not yet
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT07503925 is a Phase 4 study that has not yet begun recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 15 participants.
The verdict
NCT07503925, a Phase 4 study, has not yet begun recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
Although nicotine pouches have been gaining popularity over the last few years, little known about how nicotine pouch users actually use these products. This study will be comprised of adults who use nicotine pouches. If eligible, participants will be asked to complete three study visits and participate in two switching periods where participants use study-provided nicotine pouches.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- DRUG Nicotine Oral Pouch
- OTHER Text Message-Based Navigation Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07503925
The ClinicalTrials.gov registry entry for NCT07503925 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT07503925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07503925 about?
NCT07503925 is a clinical study titled "THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health". Although nicotine pouches have been gaining popularity over the last few years, little known about how nicotine pouch users actually use these products. This study will be comprised of adults who use nicotine pouches. If eligible, participants will be asked to complete three study visits and partic...
What is the current status of trial NCT07503925?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2026-07-01. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07503925?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Nicotine Oral Pouch (DRUG), Text Message-Based Navigation Intervention (OTHER).
Who is sponsoring clinical trial NCT07503925?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.